PATH (UiPath) Stock Analysis - Politician Trades

UiPath (PATH) is a publicly traded Technology sector company. As of May 20, 2026, PATH trades at $10.66 with a market cap of $5.54B and a P/E ratio of 20.45. PATH moved +2.04% today. Year to date, PATH is -32.81%; over the trailing twelve months it is -13.42%. Its 52-week range spans $9.20 to $19.84. Analyst consensus is neutral with an average price target of $13.33. Rallies surfaces PATH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded PATH stock?

Rallies tracks politician and congressional stock disclosures for PATH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

PATH Key Metrics

Key financial metrics for PATH
MetricValue
Price$10.66
Market Cap$5.54B
P/E Ratio20.45
EPS$0.52
Dividend Yield0.00%
52-Week High$19.84
52-Week Low$9.20
Volume31.74M
Avg Volume0
Revenue (TTM)$1.61B
Net Income$282.33M
Gross Margin83.17%

Latest PATH News

Recent PATH Insider Trades

  • Dines Daniel sold 45.00K (~$675.62K) on Jan 26, 2026.
  • Dines Daniel sold 45.00K (~$685.56K) on Jan 23, 2026.
  • Dines Daniel sold 45.00K (~$676.04K) on Jan 22, 2026.

PATH Analyst Consensus

17 analysts cover PATH: 0 strong buy, 2 buy, 14 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.33.

Common questions about PATH

Which politicians traded PATH stock?
Rallies tracks politician and congressional stock disclosures for PATH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in PATH?
Yes. Rallies tracks politician and congressional stock disclosures for PATH, including reported purchases, sales, dates, owners, and trade amounts when available.
Is PATH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PATH. It does not provide personalized investment advice.
PATH

UiPath